Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLCO1B1 | Q9Y6L6 | 4/20 | 1.00 |
| ▸ | HMGCR | P04035 | 11/20 | 0.84 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.83 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.83 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.83 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.64 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.61 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.61 |
| ▸ | PGR | P06401 | 1/20 | 0.61 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tenivastatin SCHEMBL28594403 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL28594405 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL14137685 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL3694911 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL13934502 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL25366987 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL110804 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL8239454 | 1.00 | SLCO1B1 (1.00) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL28618339 | 0.99 | SLCO1B1 (0.98) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 | |
| Tenivastatin SCHEMBL2987588 | 0.99 | SLCO1B1 (0.98) | SLCO1B1HMGCRHDAC1HDAC2HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007100351-A2 | PROCESS FOR PREPARING SIMVASTATIN AND INTERMEDIATES THEREOF | TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG (HU) | 2007-09-07 | — | — | WO | disclosed |
| US-20070129437-A1 | Process for preparing simvastatin and intermediates thereof | TEVA PHARMACEUTICALS USA, INC. | 2007-06-07 | — | — | US | disclosed |
| US-20070129437-A1 | Process for preparing simvastatin and intermediates thereof | TEVA PHARMACEUTICALS USA, INC. | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129437-A1 | Process for preparing simvastatin and intermediates thereof | HMGCR, DHCR7, VKORC1 | SLCO1B1 414/4885HMGCR 1/4885HDAC1 1796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.